Relaxin gene delivery mitigates liver metastasis and synergizes with check point therapy
Activated hepatic stellate cells are associated with fibrosis and liver metastases. Here, the authors identify an endogenous role of relaxin in regulating the activation of hepatic stellate cells and report nanoparticle-mediated relaxin gene therapy to mitigate fibrosis and liver metastasis.
Guardado en:
Autores principales: | Mengying Hu, Ying Wang, Ligeng Xu, Sai An, Yu Tang, Xuefei Zhou, Jingjing Li, Rihe Liu, Leaf Huang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6b82eb1e8cdf47688cd6f310885ad26f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Distinct activation modes of the Relaxin Family Peptide Receptor 2 in response to insulin-like peptide 3 and relaxin
por: Shoni Bruell, et al.
Publicado: (2017) -
SUMOylation inhibitors synergize with FXR agonists in combating liver fibrosis
por: Jiyu Zhou, et al.
Publicado: (2020) -
Development of a selective agonist for relaxin family peptide receptor 3
por: Dian Wei, et al.
Publicado: (2017) -
Relaxin does not improve Angiotensin II-induced target-organ damage.
por: Nadine Haase, et al.
Publicado: (2014) -
ML290 is a biased allosteric agonist at the relaxin receptor RXFP1
por: Martina Kocan, et al.
Publicado: (2017)